These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21040936)

  • 1. The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study).
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer C
    Metabolism; 2011 Jul; 60(7):969-75. PubMed ID: 21040936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
    Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
    Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
    Schindhelm RK; Diamant M; Bakker SJ; van Dijk RA; Scheffer PG; Teerlink T; Kostense PJ; Heine RJ
    Eur J Clin Invest; 2005 Jun; 35(6):369-74. PubMed ID: 15948897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.
    Graham RC; Burke A; Stettler N
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):442-9. PubMed ID: 19644391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
    Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
    Dullaart RP; de Vries R; Dallinga-Thie GM; Sluiter WJ; van Tol A
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):375-81. PubMed ID: 17877759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
    Olynyk JK; Knuiman MW; Divitini ML; Davis TM; Beilby J; Hung J
    Am J Gastroenterol; 2009 Jul; 104(7):1715-22. PubMed ID: 19491832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
    Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
    Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
    Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Wagenknecht LE; Festa A; D'Agostino RB; Haffner SM
    Diabetes Care; 2007 Jul; 30(7):1819-27. PubMed ID: 17429060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.
    Kazumi T; Kawaguchi A; Hirano T; Yoshino G
    Horm Metab Res; 2006 Feb; 38(2):119-24. PubMed ID: 16523413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower plasma adiponectin is correlated to higher alanine aminotransferase independent of metabolic factors and hepatitis B virus carrier status.
    Lu JY; Su TC; Liu YH; Hsu HJ; Chen CL; Yang WS
    Intern Med J; 2007 Jun; 37(6):365-71. PubMed ID: 17535379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
    Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.